The anti-elastase antibody NP57 is a useful addition to the range of monoclonal antibodies available for the differential diagnosis of acute leukaemia by alkaline phosphatase-antialkaline phosphatase (APAAP) labelling of cell smears; it may also be of value for the histopathological diagnosis of tumour deposits in myeloid leukaemia and for the detection of neutrophils in paraffin sections.
SUMMARY A monoclonal antibody, NP57, was produced and used against the neutrophil granule protein elastase, which selectively stain neutrophils in cryostat and paraffin wax sections. The antibody stains neutrophils and a subpopulation of monocytes in blood smears and neutrophil precursors in bone marrow smears, and gives positive reactions with the cell lines HL60 and U-937. It labelled the blast cells in 68% of cases of acute myeloid leukaemia (Ml -M5) but was unreactive with all cases of lymphoid leukaemias. Most of the elastase negative myeloid leukaemias were labelled by monoclonal anti-myeloperoxidase (antibody MPO-7) as were cells from the promyelocytic line HL60. No cases of myeloid leukaemia showed the opposite pattern-that is elastase positive, myeloperoxidase negative, suggesting that the production of myeloperoxidase precedes the onset of elastase synthesis during myeloid maturation.
The anti-elastase antibody NP57 is a useful addition to the range of monoclonal antibodies available for the differential diagnosis of acute leukaemia by alkaline phosphatase-antialkaline phosphatase (APAAP) labelling of cell smears; it may also be of value for the histopathological diagnosis of tumour deposits in myeloid leukaemia and for the detection of neutrophils in paraffin sections. The primary and secondary granules of neutrophils contain several different proteins. Some ofthese have a role in the killing of micro-organisms'2; others have proteolytic activity and may serve to break down tissue in the vicinity ofpolymorph accumulations. -5 In the present paper we describe the preparation of a monoclonal antibody NP57 specific for one of these neutrophil granule proteins-the enzyme elastase. Neutrophil elastase is a neutral protease which plays an important part in microbial killing and in initiating tissue injury.5 In previous studies (based on differential centrifugation of isolated granules) it has been localised to primary (azurophil) granules. 6 The monoclonal anti-elastase antibody described here detects a formalin resistant epitope and it can thus be used to label neutrophils in paraffin sections of routinely processed tissue. It is also of value, using the alkaline phosphatase-antialkaline phosphatase (APAAP) immunoalkaline phosphatase technique, for labelling elastase in myeloid cells in blood and bone marrow smears.78 The APAAP procedure gives minAccepted for publication 18 February 1988 imal background labelling so that trace amounts of elastase can be detected-that is, when it first appears in primary granules during myeloid maturation. This method has also shown that a subpopulation of human monocytes contain small amounts of elastase.
Besides detecting elastase in normal cells, this antibody, together with monclonal anti-myeloperoxidase, has proved to be a valuable addition to a panel of other monoclonal antibodies for phenotyping acute leukaemias.
Material and methods
Neutrophil granule proteins were extracted from myeloid cells from a patient with chronic myeloid leukaemia according to the technique described by Olsson and Venge.9 Briefly, leucocytes obtained after a dextran sedimentation of whole blood were washed, resuspended in 0-36 M sucrose and sonicated. The preparation was spun at 300 x g to remove cell nuclei and the resulting supernatant was centrifuged at 8000 x g to collect the granules. The granule contents were then extracted for 60 minutes at 4°C in 0 34 M sodium 853 854 acetate, pH 4-0. The green protein extract was then stored at -20°C.
Elastase, myeloperoxidase, and cationic chymotrypsin-like protein were purified from human neutrophils as described previously. 9 A mouse was injected three times intraperitoneally at eight day intervals with the granule protein emulsified in Freund's complete adjuvant. A fusion was carried out three days after the last injection adhering to the procedure previously described. ' In preliminary experiments (to establish optimal dilution of reagents) staining was performed using antibody NP57 or anti-lactoferrin alone, and in some of these experiments different fixatives were evaluated.
DOT BLOT ASSAY Samples of neutrophil granule extract (and of other proteins such as purified elastase, column eluates) were dotted in doubling dilution (starting at 3 7 mg/ml for granule preparation and 0-2 mg/ml for purified elastase) in aliquots of 100 p1 on to nitrocellulose paper. Free protein binding sites were blocked by incubation in 3% bovine serum albumin for 30 minutes. The paper was then stained by the APAAP immunoalkaline phosphatase technique using either the monoclonal antibody NP57, rabbit anti-elastase (produced in one of the authors' (IO) laboratories), or monoclonal anti-T cell antibody Dako-TI (as a negative control).
IMMUNOAFFINITY PURIFICATION
Antibody NP57 was isolated from ascitic fluid and coupled to CNBr-Sepharose (Pharmacia) at 5 mg/ml gel. The granule extract, diluted in 10 mM Tris 150mM sodium chloride (pH7 2), was run through a column of immunoabsorbant. The bound material was eluted with 100 mM glycine (pH2-2) and subjected to polyacrylamide gel electrophoresis. Fractions eluted from the column were also assayed for elastase activity and, by dot-blotting, for reactivity with rabbit anti-elastase and with antibody NP57.
ELASTASE ASSAY
Elastase activity was measured using a chromogenic substrate (N-succinyl-alanyl-alanyl-alanine-p-nitroanilide (Sigma).'5 The substrate was dissolved at a concentration of 22 mM in 50 mM Tris buffer (pH8-0), containing 150 mM sodium chloride and 5 mM calcium chloride. Samples of 200 p1 were added to 0-8 ml of substrate and incubation performed at 37°C for two hours. The yellow reaction product was measured at 400 nm. 3) . Dot blotting showed that this material was recognised both by the polyclonal rabbit anti-elastase and by antibody NP57 (fig 3) .
IMMUNOCYTOCHEMICAL STAINING WITH MONOCLONAL ANTI-ELASTASE
Tissue sections The antibody was tested on routine paraffin wax embedded samples from a variety of human tissues, and strong labelling ofneutrophils was obtained (figs 4 and 5) . No staining of other cells or elements in the tissue sections was observed. In crysotat sections staining of neutrophils was seen but, in contrast to the staining seen on paraffin sections, this formed an indistinct "cloud" of staining overlying individual cells (fig 6) , preventing their clear visualisation and suggesting that diffusion ofthe antigen out of neutrophils occurs when cryostat sections thaw. 10) , as was the one case of acute promyelocytic leukaemia (M3). Labelling was confined to the cytoplasm of the neoplastic cells and showed a granular distribution. In many ofthe cases of acute myeloblastic leukaemia the reactivity was restricted to a few small granules within the cell cytoplasm. The antibody did not stain any cases of lymphoid, megakaryoblastic, or erythroid leukaemia (22, four, and one case, respectively).
Comparison of staining reactions of NP57 on leukaemia samples with those of the monoclonal anti-myeloperoxidase antibody showed that a greater proportion of the myeloid malignancies (91% v 68%) were stained by anti-myeloperoxidase antibody.
One interesting aspect of blood smear labelling was Pulford, Erber, Crick, Olsson, Micklem, Gatter, Mason that in the intracellular localisation of elastase as shown by NP57 depended on the fixative used. Fixation with methanol formalin (50:50) gave the clearest localisation to neutrophil cytoplasm, whereas use of a variety of other fixatives (such as acetone or acetone/methanol/formalin) led to the antigen being localised principally to neutrophil (and monocyte) nuclei. In these preparations staining was strongest at the periphery of the nuclei, the cytoplasm of these cells often being only weakly stained or negative. This phenomenon was explored most extensively in cell smears stained by the APAAP procedure, but it was also seen in several experiments in which immunofluorescence was used as the staining technique.
STAINING OF CELL LINES
When HL60 cells were stained for elastase with NP57, about 50% were labelled, often in a localised area within the cytoplasm. In contrast, antimyeloperoxidase stained all cells in the HL60 cell line, and showed a diffuse pattern of labelling throughout the cytoplasm. U-937 cells were also stained by NP57, the cytoplasm of all cells showing extensive strong reactivity. The anti-myeloperoxidase antibody was unreactive with the U-937 cell line.
Discussion
There have been two previous reports of the preparation of polyclonal antibodies against human neutrophil elastase for immunocytochemical staining of human tissues. weaker staining of epithelial cells in the gastrointestinal tract).'6 Another polyclonal antiserum against human neutrophils was prepared (in rabbits) by Kramps et al (1984) and used for immunocytochemical staining of tissue sections and blood smears.'7 Very similar reactions to those reported by Crocker et al when staining tissue sections were shown. They also stained cells and smears from leukaemic samples and noted that elastase "is a specific marker of neutrophilic myeloid cells originating from the promyelocyte". Both these studies concluded that anti-elastase would be a valuable reagent in the study of benign and neoplastic granulocytes. Although the above reports clearly indicated that elastase may be a useful marker for detecting myeloid cells in tissue sections and cell smears, the use of polyclonal antisera (rather than monoclonal reagents) restricted its wider study in this context. Polyclonal antisera also introduce a potential risk of non-specific reactivity and background labelling in immunocytochemistry. This may account for minor discrepancies between the two reports (such as the eosinophil labelling noted by Crocker et al but not by Kramps et at).
In the present study the specificity of monoclonal antibody NP57 for elastase was shown in several ways. Firstly, it recognised an antigen consisting of three bands with molecular weights of about 23-27 kD (fig 2) , values which are close to the figure of 30 kD reported by Kramps et al '7 and The results of our study show that the true localisation of elastase in vivo is in the cell cytoplasm (rather than within nuclei), and this is supported by the way in which the enzyme behaves during cell fractionation and granule purification, and also by ultrastructural labelling studies (Cramer et al, unpublished observations). These findings, seen both for elastase and for lactoferrin, provide an instructive example of how artefacts can arise when attempting to identify the subcellular location of an antigenic molecule by immunocytochemistry.
Staining of blood and bone marrow smears with NP57 can be used in the diagnosis of acute myeloid leukaemias. We have previously reported an evaluation of more than 250 haematological samples which showed the practical value of the APAAP staining procedure (as applied to routine blood and marrow smears) for this purpose.'3 It became evident during this work, however, that there are at present relatively few satisfactory markers that can be used by this technique for the detection of myeloid leukaemias. Monoclonal antibodies My4, My7, and My9,23 which probably represent the best currently available reagents of this sort, give relatively weak labelling on cell smears. In contrast, the reactivity of the monoclonal anti-elastase antibody NP57 reported in this paper is often strong, probably because of the fact that elastase is present in neutrophil granules at relatively high local concentration (unlike surface antigens which are diffusely distributed in the cell membrane).
In our study the anti-myeloperoxidase monoclonal antibody MPO-7 labelled neoplastic cells in a greater proportion of myeloid leukaemias than NP57 (91% v 68%). This suggests that myeloperoxidase is expressed at an earlier stage of myeloid differentiation than elastase and is thus able to detect more immature myeloblasts. The fact that the HL60 line expresses myeloperoxidase in all cells, but elastase in only a proportion, also supports this view. The observation that the cell line U-937 lacked myeloperoxidase but was strongly positive for elastase is not in keeping with this hypothesis. This pattern may represent loss during in vitro culture of U-937 of the ability to express myeloperoxidase (as elastase was never found in the absence of myeloperoxidase in fresh myeloid leukaemia cells). Alternatively, the U-937 cell line may not reflect events during granulocytic maturation because of its histiocytic nature.
In conclusion, the monoclonal anti-elastase antibody NP57 described in this paper is of potential value in studies of the maturation and other aspects of normal myeloid cells. It also seems to represent a useful addition to the existing range of monoclonal antibodies for immunocytochemical labelling of cell smears in the differential diagnosis ofacute leukaemia. It may also provide a means of diagnosing solid deposits of myeloid leukaemia and of detecting myeloid infiltrates in paraffin sections.
